Top compounds associated with response to RP11-644F5.10


Feature Type Standardized
Nominal ANOVA
mRNA MS-275 CTRPv2 pan-cancer AAC -0.042 0.2
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.042 0.2
mRNA BRD-K04800985 CTRPv2 pan-cancer AAC -0.048 0.2
mRNA Sildenafil CTRPv2 pan-cancer AAC -0.048 0.2
mRNA ISOX CTRPv2 pan-cancer AAC -0.04 0.2
mRNA myriocin CTRPv2 pan-cancer AAC -0.1 0.2
mRNA Nutlin-3 CTRPv2 pan-cancer AAC 0.043 0.2
mRNA CAY10618 CTRPv2 pan-cancer AAC -0.044 0.2
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.041 0.2
mRNA GMX-1778 CTRPv2 pan-cancer AAC -0.044 0.2
Download CSV